- Home
- STAA
as 12-20-2024 4:00pm EST
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.
| Founded: | 1982 | Country: | United States |
| Employees: | N/A | City: | MONROVIA |
| Market Cap: | 1.3B | IPO Year: | N/A |
| Target Price: | $42.83 | AVG Volume (30 days): | 568.2K |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.44 | EPS Growth: | 9.97 |
| 52 Week Low/High: | $23.72 - $52.68 | Next Earning Date: | 10-30-2024 |
| Revenue: | $341,224,000 | Revenue Growth: | 10.01% |
| Revenue Growth (this year): | 8.37% | Revenue Growth (next year): | 11.70% |
Stock Insider Trading Activity of STAAR Surgical Company (STAA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| BROADWOOD PARTNERS, L.P. | STAA | 10% Owner | Dec 16 '24 | Buy | $12.24 | 80,200 | $1,947,539.94 | 10,814,651 |
Latest STAAR Surgical Company News
STAA Breaking Stock News: Dive into STAA Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
STAA: Lowering target price to $20.00
Argus Research
11 days ago
STAA: What does Argus have to say about STAA?
Argus Research
18 days ago
STAA: Lowering target price to $21.00
Argus Research
25 days ago
STAA: Raising target price to $22.00
Business Wire
a month ago
STAAR Surgical to Participate in BTIG Ophthalmology Day
Zacks
a month ago
Implied Volatility Surging for STAAR Surgical (STAA) Stock Options
Business Wire
a month ago
STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024)
Argus Research
a month ago
STAA: Lowering target price to $23.00
Compare STAA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "STAA STAAR Surgical Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.